NO971029L - Fremgangsmåter for hemming av endometriale metoser - Google Patents

Fremgangsmåter for hemming av endometriale metoser

Info

Publication number
NO971029L
NO971029L NO971029A NO971029A NO971029L NO 971029 L NO971029 L NO 971029L NO 971029 A NO971029 A NO 971029A NO 971029 A NO971029 A NO 971029A NO 971029 L NO971029 L NO 971029L
Authority
NO
Norway
Prior art keywords
metoses
methods
inhibiting endometrial
inhibiting
endometrial
Prior art date
Application number
NO971029A
Other languages
English (en)
Other versions
NO971029D0 (no
Inventor
Susan Margaret Boss-Bader
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO971029D0 publication Critical patent/NO971029D0/no
Publication of NO971029L publication Critical patent/NO971029L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Fremgangsmåte for hemming av endometriaie mitoser omfatter administrering til et individ som har behov for dette, av en effektiv mengde av en forbindelse med formel (I), R'0 OCH;j.CHi¿R -Ri (I) hvor r' og r3 er uavhengig hydrogen, -CH3, (a) eller (b), hvor Ar er eventuelt sub- stituert fenyl; R^ er valgt fra gruppen omfattende pyrolidin, heksametylenimino og piperidino; eller et farmasøytisk akseptabelt salt eller solvat derav.
NO971029A 1994-09-22 1997-03-06 Fremgangsmåter for hemming av endometriale metoser NO971029L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/310,292 US5843964A (en) 1994-09-22 1994-09-22 Methods of inhibiting endometrial mitoses
PCT/US1995/011926 WO1996009050A1 (en) 1994-09-22 1995-09-20 Methods of inhibiting endometrial mitoses

Publications (2)

Publication Number Publication Date
NO971029D0 NO971029D0 (no) 1997-03-06
NO971029L true NO971029L (no) 1997-03-06

Family

ID=23201835

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971029A NO971029L (no) 1994-09-22 1997-03-06 Fremgangsmåter for hemming av endometriale metoser

Country Status (16)

Country Link
US (1) US5843964A (no)
EP (1) EP0782446A4 (no)
JP (1) JPH10506108A (no)
KR (1) KR970706000A (no)
CN (1) CN1158086A (no)
AU (1) AU692309B2 (no)
CA (1) CA2200451A1 (no)
CZ (1) CZ83997A3 (no)
FI (1) FI971197A0 (no)
HU (1) HUT76828A (no)
IL (1) IL115383A0 (no)
MX (1) MX9702148A (no)
NO (1) NO971029L (no)
NZ (1) NZ294123A (no)
WO (1) WO1996009050A1 (no)
ZA (1) ZA957949B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ51897A3 (en) * 1994-08-22 1997-06-11 Lilly Co Eli Inhibition method of endometrial cancer
JP5005127B2 (ja) 1999-05-04 2012-08-22 ストラカン・インターナショナル・リミテッド アンドロゲングリコシド及びそのアンドロゲン作用活性
USD692738S1 (en) 2011-06-30 2013-11-05 Hellermanntyton Corporation Cable tie tensioning and cut-off tool
US9394068B2 (en) 2011-06-30 2016-07-19 Hellermann Tyton Corporation Cable tie tensioning and cut-off tool
ES2867448T3 (es) 2014-12-12 2021-10-20 Hellermanntyton Corp Mecanismo compuesto de tensado y calibración para herramienta de tensado y corte de bridas para cables

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
US5461065A (en) * 1993-10-15 1995-10-24 Eli Lilly And Company Methods for inhibiting endometriosis
MY131931A (en) * 1994-08-22 2007-09-28 Lilly Co Eli Methods of inhibiting primary endometrial hyperplasia

Also Published As

Publication number Publication date
AU692309B2 (en) 1998-06-04
JPH10506108A (ja) 1998-06-16
EP0782446A4 (en) 1999-01-07
EP0782446A1 (en) 1997-07-09
CN1158086A (zh) 1997-08-27
HUT76828A (en) 1997-11-28
NO971029D0 (no) 1997-03-06
MX9702148A (es) 1997-06-28
IL115383A0 (en) 1995-12-31
CZ83997A3 (en) 1997-07-16
NZ294123A (en) 1999-09-29
CA2200451A1 (en) 1996-03-28
AU3678895A (en) 1996-04-09
FI971197A (fi) 1997-03-21
ZA957949B (en) 1997-03-20
US5843964A (en) 1998-12-01
FI971197A0 (fi) 1997-03-21
KR970706000A (ko) 1997-11-03
WO1996009050A1 (en) 1996-03-28

Similar Documents

Publication Publication Date Title
NO971520L (no) Fremgangsmåte for hemming av tilstander forbundet med neuropeptid Y
NO973635L (no) Fremgangsmåte for hemming av celle-celle adhesjon
NO944911L (no) Ikke-peptid-takykininreseptorantagonister
DK0652005T3 (da) Fremgangsmåder til inhibering af endometriose
NO944919L (no) Fremgangsmåte for å inhibere atrofi av huden eller vagina
NO944927L (no) Fremgangsmåte for inhibering av pulmonar hypertensiv sykdom
MX9701329A (es) Metodos para la inhibicion de la replicacion viral.
MX9701325A (es) Metodos para inhibir la mucositis ulcerativa.
MX9701360A (es) Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion.
DK0659417T3 (da) Fremgangsmåder til inhibering af dysfunktionel blødning fra livmoderen
NO944914L (no) Fremgangsmåte for å inhibere autoimmunsykdommer
NO944933L (no) Fremgangsmåte for å inhibere sykdomstilstander i brystet
NO944924L (no) Fremgangsmåter for inhibering av Turner's syndrom
NO944917L (no) Anvendelse av 2-fenyl-3-aroyltiofener for inhibering av ovarial dysgenese, forsinket pubertet eller seksuell infantilisme
NO975580L (no) Fremgangsmåte for å inhibere melanom
NO970786L (no) Fremgangsmåte for hemming av benprotesedegradering
NO971029L (no) Fremgangsmåter for hemming av endometriale metoser
EA199700136A1 (ru) Способы ингибирования экзогенных эстрогенов
NO981578L (no) FremgangsmÕte for hemming av plasminogenaktivatorhemmer I
NO973609L (no) Fremgangsmåte for å inhibere effektene av IL-6
NO944577L (no) Hemming av effekten av amyloidogene proteiner
NO971794L (no) Fremgangsmåte for hemming av tilstander forbundet med bradykinin
NO970783L (no) Fremgangsmåte for å hindre endometrialkreft
MX9701333A (es) Metodos para inhibir el daño neuronal.
NO20000750L (no) FremgangsmÕte for Õ redusere blodplatetall